{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T02:11:19Z","timestamp":1762913479867,"version":"3.45.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T00:00:00Z","timestamp":1666051200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine: X"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.jvacx.2022.100230","type":"journal-article","created":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T13:11:24Z","timestamp":1666185084000},"page":"100230","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Intramuscular injection of a mixture of COVID-19 peptide vaccine and tetanus vaccine in horse induced neutralizing antibodies against authentic virus of SARS-CoV-2 Delta variant"],"prefix":"10.1016","volume":"12","author":[{"given":"Weiwen","family":"Deng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond W.","family":"Sweeney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jvacx.2022.100230_b0005","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1039\/C5SC03892H","article-title":"Peptide-based synthetic vaccines","volume":"7","author":"Skwarczynski","year":"2016","journal-title":"Chem Sci"},{"issue":"3","key":"10.1016\/j.jvacx.2022.100230_b0010","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1021\/acsabm.1c01238","article-title":"Peptides for Vaccine Development","volume":"5","author":"Hamley","year":"2022","journal-title":"ACS Appl Bio Mater"},{"key":"10.1016\/j.jvacx.2022.100230_b0015","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.R120.002309","article-title":"The Peptide Vaccine of the Future","volume":"20","author":"Nelde","year":"2021","journal-title":"Mol Cell Proteomics."},{"issue":"4","key":"10.1016\/j.jvacx.2022.100230_b0020","doi-asserted-by":"crossref","first-page":"856","DOI":"10.3390\/pharmaceutics14040856","article-title":"Peptide-Based Vaccine against SARS-CoV-2: Peptide Antigen Discovery and Screening of Adjuvant Systems","volume":"14","author":"Shalash","year":"2022","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.jvacx.2022.100230_b0025","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s10989-022-10397-y","article-title":"Peptide-Based Vaccines and Therapeutics for COVID-19","volume":"28","author":"Bagwe","year":"2022","journal-title":"Int J Pept Res Ther."},{"key":"10.1016\/j.jvacx.2022.100230_b0030","doi-asserted-by":"crossref","unstructured":"Parums DV. Editorial: First Approval of the Protein-Based Adjuvanted Nuvaxovid (NVX-CoV2373) Novavax Vaccine for SARS-CoV-2 Could Increase Vaccine Uptake and Provide Immune Protection from Viral Variants. Med Sci Monit. 2022 Mar 1;28: e936523. 10.12659\/MSM.936523. PMID: 35228506; PMCID: PMC8897963.","DOI":"10.12659\/MSM.936523"},{"issue":"6483","key":"10.1016\/j.jvacx.2022.100230_b0035","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science."},{"key":"10.1016\/j.jvacx.2022.100230_b0040","doi-asserted-by":"crossref","unstructured":"Cai Y, Zhang J, Xiao T, Peng H, Sterling SM, Walsh RM Jr, et al. Distinct conformational states of SARS-CoV-2 spike protein. Science. 2020 Sep 25;369(6511):1586-1592. 10.1126\/science. abd4251. Epub 2020 Jul 21. PMID: 32694201; PMCID: PMC7464562.","DOI":"10.1126\/science.abd4251"},{"key":"10.1016\/j.jvacx.2022.100230_b0045","doi-asserted-by":"crossref","unstructured":"Nidom RV, Indrasari S, Normalina I, Nidom AN, Afifah B, Dewi L, et al. Phylogenetic and full-length genome mutation analysis of SARS-CoV-2 in Indonesia prior to COVID-19 vaccination program in 2021. Bull Natl Res Cent. 2021;45(1):200. 10.1186\/s42269-021-00657-0. Epub 2021 Nov 21. PMID: 34840498; PMCID: PMC8606223.","DOI":"10.1186\/s42269-021-00657-0"},{"key":"10.1016\/j.jvacx.2022.100230_b0050","doi-asserted-by":"crossref","unstructured":"Fahmi, M., Kharisma, V.D., Ansori, A.N.M., Ito, M. (2021). Retrieval and Investigation of Data on SARS-CoV-2 and COVID-19 Using Bioinformatics Approach. In: Rezaei, N. (eds) Coronavirus Disease - COVID-19. Advances in Experimental Medicine and Biology, vol 1318. Springer, Cham. https:\/\/doi.org\/10.1007\/978-3-030-63761-3_47.","DOI":"10.1007\/978-3-030-63761-3_47"},{"issue":"7852","key":"10.1016\/j.jvacx.2022.100230_b0055","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/s41586-021-03361-1","article-title":"SARS-CoV-2 spike D614G change enhances replication and transmission","volume":"592","author":"Zhou","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jvacx.2022.100230_b0060","doi-asserted-by":"crossref","unstructured":"Peisahovics F, Rohaim MA, Munir M. Structural topological analysis of spike proteins of SARS-CoV-2 variants of concern highlight distinctive amino acid substitution patterns. Eur J Cell Biol. 2022 Sep 19;101(4):151275. 10.1016\/j.ejcb.2022.151275. Epub ahead of print. PMID: 36156414; PMCID: PMC9484102.","DOI":"10.1016\/j.ejcb.2022.151275"},{"issue":"5","key":"10.1016\/j.jvacx.2022.100230_b0065","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/s41591-022-01753-y","article-title":"Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants","volume":"28","author":"Tseng","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.jvacx.2022.100230_b0070","doi-asserted-by":"crossref","unstructured":"Iketani S, Liu L, Guo Y, Liu L, Chan JF, Huang Y, et al. Antibody evasion properties of SARS-CoV-2 Omicron sublineages. Nature. 2022 Apr;604(7906):553-556. 10.1038\/s41586-022-04594-4. Epub 2022 Mar 3. PMID: 35240676; PMCID: PMC9021018.","DOI":"10.1038\/s41586-022-04594-4"},{"key":"10.1016\/j.jvacx.2022.100230_b0075","doi-asserted-by":"crossref","unstructured":"Cao Y, Wang J, Jian F, Xiao T, Song W, Yisimayi A, et al. Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies. Nature. 2022 Feb;602(7898):657-663. 10.1038\/s41586-021-04385-3. Epub 2021 Dec 23. PMID: 35016194; PMCID: PMC8866119.","DOI":"10.1038\/s41586-021-04385-3"},{"issue":"6485","key":"10.1016\/j.jvacx.2022.100230_b0080","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1126\/science.abb2762","article-title":"Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2","volume":"367","author":"Yan","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jvacx.2022.100230_b0085","doi-asserted-by":"crossref","unstructured":"Huang Y, Yang C, Xu XF, Xu W, Liu SW. Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19. Acta Pharmacol Sin. 2020 Sep;41(9):1141-1149. 10.1038\/s41401-020-0485-4. Epub 2020 Aug 3. PMID: 32747721; PMCID: PMC7396720.","DOI":"10.1038\/s41401-020-0485-4"},{"issue":"6","key":"10.1016\/j.jvacx.2022.100230_b0090","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jmv.25726","article-title":"Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2","volume":"92","author":"Liu","year":"2020","journal-title":"J Med Virol"},{"key":"10.1016\/j.jvacx.2022.100230_b0095","doi-asserted-by":"crossref","unstructured":"Heitmann JS, Bilich T, Tandler C, Nelde A, Maringer Y, Marconato M, et al. A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity. Nature. 2022 Jan;601(7894):617-622. 10.1038\/s41586-021-04232-5. Epub 2021 Nov 23. PMID: 34814158; PMCID: PMC8791831.","DOI":"10.1038\/s41586-021-04232-5"},{"issue":"1","key":"10.1016\/j.jvacx.2022.100230_b0100","doi-asserted-by":"crossref","first-page":"14179","DOI":"10.1038\/s41598-020-70864-8","article-title":"Immunoinformatic identification of B cell and T cell epitopes in the SARS-CoV-2 proteome","volume":"10","author":"Crooke","year":"2020","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.jvacx.2022.100230_b0105","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3390\/vaccines8030355","article-title":"Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design","volume":"8","author":"Wang","year":"2020","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"10.1016\/j.jvacx.2022.100230_b0110","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12929-021-00740-8","article-title":"Identification of COVID-19 B-cell epitopes with phage-displayed peptide library","volume":"28","author":"Guo","year":"2021","journal-title":"J Biomed Sci"},{"issue":"2","key":"10.1016\/j.jvacx.2022.100230_b0115","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3390\/vaccines10020251","article-title":"Immunodominant Linear B-Cell Epitopes of SARS-CoV-2 Spike, Identified by Sera from K18-hACE2 Mice Infected with the WT or Variant Viruses","volume":"10","author":"Levy","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.jvacx.2022.100230_b0120","doi-asserted-by":"crossref","unstructured":"Grifoni A, Sidney J, Vita R, Peters B, Crotty S, Weiskopf D, et al. SARS-CoV-2 human T cell epitopes: Adaptive immune response against COVID-19. Cell Host Microbe. 2021 Jul 14;29(7):1076-\u2013092. 10.1016\/j.chom.2021.05.010. Epub 2021 May 21. PMID: 34237248; PMCID: PMC8139264.","DOI":"10.1016\/j.chom.2021.05.010"}],"container-title":["Vaccine: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590136222000900?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590136222000900?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T02:08:42Z","timestamp":1762913322000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590136222000900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":24,"alternative-id":["S2590136222000900"],"URL":"https:\/\/doi.org\/10.1016\/j.jvacx.2022.100230","relation":{},"ISSN":["2590-1362"],"issn-type":[{"type":"print","value":"2590-1362"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intramuscular injection of a mixture of COVID-19 peptide vaccine and tetanus vaccine in horse induced neutralizing antibodies against authentic virus of SARS-CoV-2 Delta variant","name":"articletitle","label":"Article Title"},{"value":"Vaccine: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvacx.2022.100230","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100230"}}